Carrollton, TX, United States of America

Richard H Scheuermann

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 205(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Richard H. Scheuermann

Introduction

Richard H. Scheuermann is a notable inventor based in Carrollton, TX (US). He has made significant contributions to the field of immunology, particularly in the development of monoclonal antibodies and cancer treatment methodologies. With a total of 2 patents, his work has had a profound impact on therapeutic strategies for various diseases.

Latest Patents

Scheuermann's latest patents include groundbreaking innovations such as "Epitope-specific monoclonal antibodies and immunotoxins and uses thereof." This patent demonstrates the enhanced anti-tumor activity of a mixture of anti-CD22 and anti-CD19 immunotoxins in SCID/Daudi mice with disseminated human Daudi lymphoma. The findings reveal that combinations of these immunotoxins act synergistically, providing advantageous compositions and methods for immunotherapeutic treatment of cancer and autoimmune disorders. Additionally, he has developed a "Method for identifying tumor cells in cell cycle arrest," which outlines novel techniques for identifying and characterizing tumor cell types within malignant populations. This method has implications for cancer treatment, as it allows for the purification and characterization of tumor cells based on various biological markers.

Career Highlights

Throughout his career, Richard H. Scheuermann has worked with prestigious organizations such as the University of Texas System and Genentech, Inc. His research has been pivotal in advancing the understanding of immunological responses and cancer therapies.

Collaborations

Some of his notable collaborators include Jonathan W. Uhr and Ellen S. Vitetta. Their combined expertise has contributed to the success of various research initiatives and innovations in the field.

Conclusion

Richard H. Scheuermann's contributions to immunology and cancer treatment exemplify the importance of innovation in medical research. His patents and collaborative efforts continue to influence therapeutic strategies and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…